Deals Of The Week: Evolva/Arpida; Genzyme/Targeted Genetics; Biotechnol/Digna Biotech/Genentech
Executive Summary
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.
You may also be interested in...
You Call That An Offer? Facet Rejects Biogen's Hostile $355 Million Bid.
Having twice said no and adopting a poison pill plan, the former R&D shop at PDL will stay independent--for now.
Shell Game: Difficult Time For Reverse Mergers
Reverse mergers are an increasingly common fundraising strategy for biotech. But do they pay off?
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011